다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

홈
인베스팅
주식
미국
USOTC
MedinCell (EM) (MDCLF) 시세

MedinCell (EM) (MDCLF)

34.39

0.00

(0.00%)

마감 04 6월 5:00AM

MedinCell (EM) (MDCLF) 주식 가격

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

34.39

( - )

매수가

0.00

매도가

0.00

거래량

-

0.00 일간 변동폭 0.00

6.9757 52주 범위 34.39

market_cap

전일 종가

34.39

개장가

-

최근 거래 시간

마지막 거래 시간

재정 규모

-

VWAP

-

평균 볼륨(3m)

US$ 107,191

발행 주식

35,904,117

배당수익률

주가수익률

-44.61

주당순이익(EPS)

-0.63

매출

32.44M

순이익

-19.95M

MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophreni... MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France. 더 보기

섹터

Healthcare

산업

Biotechnology & Life Sciences

웹사이트

www.medincell.com

본부

Jacou, France

설립됨

2026

MedinCell (EM) is listed in the Healthcare sector of the OTC 시장 with ticker MDCLF. The last closing price for MedinCell (EM) was US$34.39. Over the last year, MedinCell (EM) shares have traded in a share price range of US$ 6.9757 to US$ 34.39.

MedinCell (EM) currently has 35,904,117 shares in issue. The market capitalisation of MedinCell (EM) is US$1.23 billion. MedinCell (EM) has a price to earnings ratio (PE ratio) of -44.61.

표시할 뉴스가 없습니다.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	34.39	34.39	34.39	0	0	CS
26	27.4143	392.997118569	6.9757	34.39	6.9757	49	34.39	CS
52	27.4143	392.997118569	6.9757	34.39	6.9757	89	13.30207692	CS
156	27.4046	392.312537578	6.9854	34.39	6.9746	897	7.43389735	CS
260	20.39	145.642857143	14	34.39	6.9746	1387	9.20560969	CS

MDCLF - Frequently Asked Questions (FAQ)

What is the current MedinCell (EM) share price?

The current share price of MedinCell (EM) is US$ 34.39

How many MedinCell (EM) shares are in issue?

MedinCell (EM) has 35,904,117 shares in issue

What is the market cap of MedinCell (EM)?

The market capitalisation of MedinCell (EM) is USD 1.23B

What is the 1 year trading range for MedinCell (EM) share price?

MedinCell (EM) has traded in the range of US$ 6.9757 to US$ 34.39 during the past year

What is the PE ratio of MedinCell (EM)?

The price to earnings ratio of MedinCell (EM) is -44.61

What is the cash to sales ratio of MedinCell (EM)?

The cash to sales ratio of MedinCell (EM) is 31.28

What is the registered address of MedinCell (EM)?

The registered address for MedinCell (EM) is 3 Rue des Frères Lumière, Jacou, Languedoc-Roussillon, 34830

What is the MedinCell (EM) website address?

The website address for MedinCell (EM) is www.medincell.com

Which industry sector does MedinCell (EM) operate in?

MedinCell (EM) operates in the Biotechnology & Life Sciences sector

BottomBounce

BottomBounce 2 분 전

$HYSR SunHydrogen (HYSR) Products & Technologies
SunHydrogen Panel Technology
Their flagship product concept: a solar-powered panel that produces green hydrogen directly from sunlight and water. It’s designed to function like a traditional solar panel, but instead of generating elect

HyGro

HyGro 3 분 전

The "B" stands for biologics.

BottomBounce

BottomBounce 3 분 전

$KNDI Kandi Technologies (KNDI) — Full Product & Service Portfolio
Electric Vehicles
Kandi builds several categories of electric transportation, mostly compact and utility-focused.

Urban Electric Cars — small, affordable EVs designed for city driving

Neigh

BottomBounce

BottomBounce 3 분 전

$KNDI Kandi Technologies (KNDI) — Full Product & Service Portfolio
Electric Vehicles
Kandi builds several categories of electric transportation, mostly compact and utility-focused.

Urban Electric Cars — small, affordable EVs designed for city driving

Neigh

BottomBounce

BottomBounce 4 분 전

$BYND Beyond Meat (BYND) – Complete Product & Service Overview
🌱 Core Retail Products
Beyond Burger — flagship plant-based beef patty designed to replicate the flavor and texture of a traditional burger.

Beyond Beef — ground-beef alternative used for tacos, sauce

BottomBounce

BottomBounce 4 분 전

$BYND Beyond Meat (BYND) – Complete Product & Service Overview
🌱 Core Retail Products
Beyond Burger — flagship plant-based beef patty designed to replicate the flavor and texture of a traditional burger.

Beyond Beef — ground-beef alternative used for tacos, sauce

Guido2

Guido2 5 분 전

You're absolutely right. I don't think Pulte needs Senate confirmation for his interim position. Since I'm limited on the number of posts, forgive me for going off subject:

https://x.com/GuidoPerei/status/2062286733002334572?s=20

Trum

How is this scam still trading?

Rite has no mining equipment
Rite has no mining experience
Rite has no minable land

Rite scam waaaay past the right time..... it's actually harder to fool folks a third time using the same scam story of Skull Valley that

Slojab

Slojab 5 분 전

Q2 report is out.

Revenue down to just $101,529 which is the lowest reported in three years. And a loss of course.

Here's an interesting statement.

Management believes Primecare Supply represents a core growth engine for Global Technologies, Ltd., offerin

Lime Time

Lime Time 5 분 전

$2800 moved it 200%, imagine when we start seeing $280,000 days again. Easy 1000s% gains coming. Still zero dilution here. Some ignoring the fact that not a single share diluted.

https://investorshub.advfn.com/uimage/uploads/2026/6/3/vrrhwUntitled.png

------

Golden Cross

Golden Cross 5 분 전

Nice volume starting up

DTGoody

DTGoody 6 분 전

It's not going to take much to move us. Of course you will always have the 💩 heads who dump into the bids on every stock. With solid military defense contract news those guppies will lose all of their shares and they will be chasing when they realize that they are about to be left behind! I

larrybaz

larrybaz 6 분 전

A prophet is a prophet! (eom)

BottomBounce

BottomBounce 7 분 전

🔌 Plug Power: Full Product & Service Portfolio (Rewritten Clearly & Completely)
Hydrogen Fuel Cell Power Systems
GenDrive fuel cells — Drop-in replacements for lead-acid batteries used in electric forklifts across Class 1, 2, and 3 vehicles.

ProGen fuel cell engi

arachnodude

arachnodude 7 분 전

MY AI SAYS...

When someone writes thousands of words explaining why a company can't possibly do what it claims while the company continues doing more things that supposedly weren't possible...

At some point they're no longer documenting failure...

They’re

BottomBounce

BottomBounce 7 분 전

🔌 Plug Power: Full Product & Service Portfolio (Rewritten Clearly & Completely)
Hydrogen Fuel Cell Power Systems
GenDrive fuel cells — Drop-in replacements for lead-acid batteries used in electric forklifts across Class 1, 2, and 3 vehicles.

ProGen fuel cell engi

eb0783

eb0783 8 분 전

Yes, and let's hope about 600,000 of them have not bought yet.......that's a lot of possible investment for a small amount of free float. :-)

urge2surge

urge2surge 8 분 전

Shoe fits..

GolfnutBoston

Re: None

Friday, 01/30/2026 9:42:20 AM
Damn, back to the 2's. Where's the bottom?

quigley24

quigley24 8 분 전

one trade no biggie.........someone just gave his shares away.... sad for them

Guido2

Guido2 9 분 전

https://x.com/GuidoPerei/status/2062286733002334572?s=20

polska

polska 10 분 전

Well Edna, as an aging south paw, this might benefit you some day.

WorstLuck

WorstLuck 11 분 전

Jefferies - FDMT, EYPT (OCUL)

Just a housekeeping note. Both FDMT and EYPT presented, both with essentially the same well-polished presentations they have given recently with no notable updates or inferences.

OCUL is not doing this conference, yesterday they PR'd more

PhantomEnchanter891

PhantomEnchanter891 12 분 전

True. More like a biotech awaiting FDA approval.

Once it gets the nod and zooms based on regulatory approval, no one starts thinking about the gap.

HyGro

HyGro 13 분 전

Likely to assess the dubious P3 clinical trial REdesign after the trial was virtually completed. The final trial design was very different than the original trial design that was approved by the FDA and MHRA. The FDA is clearly not buying it as otherwise NWBO would have filed in the U.S. which

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

ADVFN

계정이 있으신가요? 로그인

계정이 없으신가요? 등록

등록함으로써 나는 ADVFN의 이용 약관 을 읽고 이해했으며 이에 동의하며 개인 투자자임을 확인합니다.